, but a
signiﬁcant increase in myocardial infarction compared with CAS during the ﬁrst 30 days. When the long-term outcome of
transfemoral CAS vs CEA in symptomatic patients were examined using preplanned pooled analysis of individual patient
data from four randomized trials, the risk of death or stroke within 120 days of the index procedure was 5.5% for CEA and
8.7% for CAS, which